During the past decade, c/o Hemodynamics Offices conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "c/o Hemodynamics Offices" are "Diabetes Mellitus, Type 2" (1 trials), "Hypertension" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "c/o Hemodynamics Offices" in a lesser frequency.

Most popular intervention types in "c/o Hemodynamics Offices" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "10 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler" (1 trials), "5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler" (1 trials), "telmisartan combined with hydrochlorothiazide (80/12.5 mg)" (1 trials) and "valsartan combined with hydrochlorothiazide (160/12.5mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "c/o Hemodynamics Offices" are 2 trials for "All" genders.

Currently, there are NaN active trials in "c/o Hemodynamics Offices". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in c/o Hemodynamics Offices, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in c/o Hemodynamics Offices, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".